Theravance Biopharma, Inc. (TBPH) Operating cash flow 2016–2025
Theravance Biopharma, Inc. (TBPH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$238.5MFY2025 · since FY2016: -$99.0M → $238.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $238.5M | +2168.0% |
| FY2024 | -$11.5M | +57.3% |
| FY2023 | -$27.0M | +85.6% |
| FY2022 | -$187.0M | +10.0% |
| FY2021 | -$207.9M | +17.0% |
| FY2020 | -$250.4M | -5.1% |
| FY2019 | -$238.2M | -111.0% |
| FY2018 | -$112.9M | +43.9% |
| FY2017 | -$201.1M | -103.1% |
| FY2016 | -$99.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice